Arrien Pharmaceuticals LLC
Records under this name other than the patents Arrien Pharmaceuticals LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 2 of 2 · Back to Arrien Pharmaceuticals LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,359,315 | Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis Formerly held In force · High confidence | In force | High confidence | |
| US 9,890,153 | Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors Lapsed on the fee record Ended Feb 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 13, 2026 | From the USPTO record |